ProKidney Corp.
Kristen Tomlinson is an experienced professional in grief support and organ donation facilitation, currently serving as Manager of QA Training at ProKidney Corp since May 2024. Kristen co-created Life, Grief & Co. in January 2020, focusing on discussions surrounding mental health and grief. Previous roles include Donation Coordinator at Donor Staff Support, where responsibilities involved supporting donor families and managing donation processes; Director of Grief Support Services at Taylor's Gift Foundation; and Donor Center Manager at Miracles In Sight. Kristen also held positions at Community Tissue Services and Life Connection of Ohio, developing expertise in donor referrals and family services. Education credentials include a Master of Education in Mental Health Counseling from Lindsey Wilson College and a Bachelor of Science in English Language and Literature and Communications from Wright State University.
This person is not in any offices
ProKidney Corp.
ProKidney (Nasdaq: PROK), a pioneer in the treatment of CKD through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney’s lead product candidate, REACT™ (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular therapy with the potential to not only slow and stabilize the progression of CKD, but in some cases potentially drive meaningful improvement in kidney function. Late-stage CKD, Stage 3b - 4, is a key target for REACT™ therapy. REACT™ has received Regenerative Medicine Advanced Therapy (RMAT) designation, as well as FDA and EMA guidance, supporting its ongoing Phase 3 clinical program, which launched in January 2022. For more information, visit www.prokidney.com.